LLR Partners Makes Growth Investment in Genesee Scientific
October 19, 2021
LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.
- Buyers
- LLR Partners
- Targets
- Genesee Scientific
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
LLR Partners Makes Strategic Investment in AxisCare
June 2, 2026
Cloud & SaaS
AxisCare, a provider of home care management software, announced a strategic growth investment from LLR Partners to accelerate product innovation and organizational expansion. Existing investor Frontier Growth will remain an active partner following the transaction.
-
Genesee Scientific Acquires Jade Scientific
September 15, 2025
Healthcare Services
Genesee Scientific, a portfolio company backed by LLR Partners, has acquired Jade Scientific, a Michigan-based distributor of chemicals and consumables for clinical reference, pharma/biotech, and environmental labs. The add-on expands Genesee’s lab essentials portfolio, broadening product offerings and strengthening service capabilities for customers nationwide.
-
LLR Partners Makes Growth Investment in TruTechnologies
May 28, 2025
Healthcare Services
LLR Partners has made a strategic growth investment in TruTechnologies, a provider of real-time clinical trial oversight and sample-management software. The capital will support TruTechnologies' product and commercial expansion; BofA served as exclusive financial advisor to TruTechnologies while Wachtell, Lipton, Rosen & Katz and DLA Piper served as legal advisors to the respective parties.
-
LLR Partners Invests in Azalea Health
March 2, 2021
Healthcare Services
LLR Partners completed a growth investment in Azalea Health to provide capital for product innovation, organic expansion and potential acquisitions. The funding supports Azalea’s cloud-based EHR, telehealth and revenue cycle management SaaS platform for community and ambulatory healthcare providers.
-
Ampersand Capital Partners Invests in Genezen Laboratories
January 5, 2021
Biotechnology
Ampersand Capital Partners has made a majority growth-equity investment in Genezen Laboratories, a cell and gene therapy CDMO, to fund completion of a 25,000 sq. ft. cGMP lentiviral vector production facility and expand process development and analytical testing capabilities. The capital will support Genezen's capability expansion across upstream/downstream processing, analytical testing, and cGMP vector production to serve early‑phase and growth-stage cell and gene therapy developers.
-
Lakelet Capital Acquires GenTech Scientific
September 30, 2020
Industrial Services
Buffalo-based private equity firm Lakelet Capital has completed an investment to support the buyout of GenTech Scientific, a refurbisher, reseller, and servicer of analytical laboratory instrumentation based in Arcade, New York. The investment provides growth capital to enhance operations, extend geographic reach, and expand solution offerings; Lakelet also installed Michael Lippa as CEO and worked with GenTech founder Clair Bragg on the transition.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.